Cord Blood America’s CEO, Matthew Schissler, discussed recent funding and his plans to continue acquiring companies on MoneyTV earlier this week. The financial television program is broadcasted to 45 million homes in Western Europe and 75 million homes in the U.S.
Cord Blood recently reported that revenues increased 121% for the nine months ended November 30, 2007 compared to the same period in 2006. Mr. Schissle commented on the results, “’The significant increase in revenue is partially due to the accretive acquisitions Cord Blood America has made, which increased the number of umbilical cord samples, and increased marketing efforts.”
Cord Blood America is focused on storing umbilical cord blood stem cells, which may be used later to cure a growing number of diseases including cancer, leukemia, blood, and immune disorders. The Company’s goal is to become the most respected stem cell preservation company in the industry and has made positive steps forward to achieving its initiative.
Let us hear your thoughts below: Cord Blood America Inc. Message Board
